Merge Healthcare and Heart Imaging Technologies (Heart IT) have entered into a non-exclusive patent licence and settlement agreement.
The agreement provides Merge with access to Heart IT's complete portfolio of healthcare information patents, including its zero-footprint technologies, which provide access to diagnostic-quality images in a standard web browser. The agreement also settles the litigation initiated by Heart IT against Merge in September 2012 for alleged patent infringement related to internet-based image viewing. As part of the settlement, Merge has agreed to not challenge the validity or enforceability of Heart IT's zero footprint patents.
Justin Dearborn, CEO of Merge, stated that the settlement also creates new development opportunities for the company to collaborate with Heart IT on future solutions. Merge stated that it remains focused on providing industry leading imaging solutions that enable advanced interoperability across the enterprise and support standards and regulatory initiatives, such as Meaningful Use Stage 2.
Heart IT's flagship product, WebPAX, was the first FDA-approved zero-footprint medical image workstation. It provides web-based medical image management technology and services to healthcare systems, large hospitals and private clinics, as well as drug and device companies sponsoring multicentre clinical trials.